One of America’s leading private equity firms is circling Morrisons – and it looks like becoming the most controversial takeover approach for a British company since Pfizer’s tilt at AstraZeneca seven years ago.
Source: Sky Business News
One of America’s leading private equity firms is circling Morrisons – and it looks like becoming the most controversial takeover approach for a British company since Pfizer’s tilt at AstraZeneca seven years ago.
Source: Sky Business News